$OMDA
Omada Health, Inc.
CIK:0001611115|SEC Filings
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($) shares in Thousands |
3 Months Ended | 6 Months Ended | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|||||||||||||
| Revenue | ||||||||||||||||
| Total revenue | $ 87,835,000 | $ 61,371,000 | $ 165,883,000 | $ 116,334,000 | ||||||||||||
| Cost of revenue | ||||||||||||||||
| Total cost of revenue | 24,048,000 | 21,065,000 | 53,403,000 | 44,128,000 | ||||||||||||
| Gross profit | 63,787,000 | 40,306,000 | 112,480,000 | 72,206,000 | ||||||||||||
| Operating expenses | ||||||||||||||||
| Research and development | [1] | 14,625,000 | 10,024,000 | 27,322,000 | 18,830,000 | |||||||||||
| Sales and marketing | [2] | 29,888,000 | 22,318,000 | 56,675,000 | 42,488,000 | |||||||||||
| General and administrative | [3] | 15,725,000 | 12,308,000 | 29,715,000 | 23,628,000 | |||||||||||
| Total operating expenses | 60,238,000 | 44,650,000 | 113,712,000 | 84,946,000 | ||||||||||||
| Operating income (loss) | 3,549,000 | (4,344,000) | (1,232,000) | (12,740,000) | ||||||||||||
| Other income (expense), net | ||||||||||||||||
| Interest expense | (14,000) | (1,094,000) | (32,000) | (2,168,000) | ||||||||||||
| Interest income | 1,759,000 | 863,000 | 3,588,000 | 1,405,000 | ||||||||||||
| Change in fair value of warrant liabilities | 0 | (736,000) | 0 | (1,256,000) | ||||||||||||
| Total other income (expense), net | 1,745,000 | (967,000) | 3,556,000 | (2,019,000) | ||||||||||||
| Income (loss) before provision for income taxes | 5,294,000 | (5,311,000) | 2,324,000 | (14,759,000) | ||||||||||||
| Provision for income taxes | 0 | 0 | 0 | 0 | ||||||||||||
| Net income (loss) and comprehensive income (loss) | 5,294,000 | (5,311,000) | 2,324,000 | (14,759,000) | ||||||||||||
| Net income (loss) and comprehensive income (loss) | $ 5,294,000 | $ (5,311,000) | $ 2,324,000 | $ (14,759,000) | ||||||||||||
| Net income (loss) per share | ||||||||||||||||
| Basic (in dollars per share) | $ 0.09 | $ (0.24) | $ 0.04 | $ (0.98) | ||||||||||||
| Diluted (in dollars per share) | $ 0.08 | $ (0.24) | $ 0.04 | $ (0.98) | ||||||||||||
| Weighted-average shares outstanding | ||||||||||||||||
| Basic (in shares) | 59,685 | 21,971 | 59,306 | 15,107 | ||||||||||||
| Diluted (in shares) | 63,947 | 21,971 | 64,345 | 15,107 | ||||||||||||
| Services | ||||||||||||||||
| Revenue | ||||||||||||||||
| Total revenue | [4] | $ 80,692,000 | $ 56,960,000 | $ 150,286,000 | $ 106,456,000 | |||||||||||
| Cost of revenue | ||||||||||||||||
| Total cost of revenue | [5] | 13,609,000 | 12,673,000 | 28,058,000 | 25,417,000 | |||||||||||
| Hardware | ||||||||||||||||
| Revenue | ||||||||||||||||
| Total revenue | [6] | 7,143,000 | 4,411,000 | 15,597,000 | 9,878,000 | |||||||||||
| Cost of revenue | ||||||||||||||||
| Total cost of revenue | $ 10,439,000 | $ 8,392,000 | $ 25,345,000 | $ 18,711,000 | ||||||||||||
| ||||||||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands |
Jun. 30, 2026 |
Dec. 31, 2025 |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | ||||||||||||
| Cash and cash equivalents | $ 221,712 | $ 222,036 | ||||||||||
| Accounts receivable, net | [1] | 56,573 | 34,585 | |||||||||
| Inventory | 4,119 | 4,486 | ||||||||||
| Deferred commissions, current | 3,959 | 3,539 | ||||||||||
| Prepaid expenses and other current assets | [2] | 8,548 | 8,288 | |||||||||
| Total current assets | 294,911 | 272,934 | ||||||||||
| Property and equipment, net | 9,098 | 7,942 | ||||||||||
| Deferred commissions, non-current | 9,222 | 8,711 | ||||||||||
| Intangible assets, net | 1,536 | 2,414 | ||||||||||
| Goodwill | 13,240 | 13,240 | ||||||||||
| Other assets | 215 | 165 | ||||||||||
| Total assets | 328,222 | 305,406 | ||||||||||
| Current liabilities | ||||||||||||
| Accounts payable | [3] | 11,804 | 10,276 | |||||||||
| Accrued expenses and other current liabilities | [4] | 35,978 | 40,392 | |||||||||
| Deferred revenue | [5] | 27,701 | 25,058 | |||||||||
| Total current liabilities | 75,483 | 75,726 | ||||||||||
| Other liabilities, non-current | 0 | 0 | ||||||||||
| Total liabilities | 75,483 | 75,726 | ||||||||||
| Commitments and contingencies (Note 5) | ||||||||||||
| Stockholders’ equity | ||||||||||||
| Common stock, $0.001 par value per share; 750,000 shares authorized as of June 30, 2026 and December 31, 2025, respectively; 60,607 and 58,429 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 61 | 58 | ||||||||||
| Additional paid-in capital | 707,098 | 686,366 | ||||||||||
| Accumulated deficit | (454,420) | (456,744) | ||||||||||
| Total stockholders’ equity | 252,739 | 229,680 | ||||||||||
| Total liabilities and stockholders’ equity | $ 328,222 | $ 305,406 | ||||||||||
| ||||||||||||